Teva Pharmaceutical Industries Limited (TEVA)

Teva Pharmaceutical Revenue

Teva Pharmaceutical had revenue of $3.89B in the quarter ending March 31, 2025, with 1.89% growth. This brings the company's revenue in the last twelve months to $16.62B, up 3.82% year-over-year. In the year 2024, Teva Pharmaceutical had annual revenue of $16.54B with 4.40% growth.

• Revenue (ttm): $16.62B
• Revenue Growth: +3.82%
• P/S Ratio: 1.21
• Revenue / Employee: $451,154
• Employees: 36,830
• Market Cap: 20.67B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	16.54B	698.00M	4.40%
Dec 31, 2023	15.85B	921.00M	6.17%
Dec 31, 2022	14.93B	-953.00M	-6.00%
Dec 31, 2021	15.88B	-781.00M	-4.69%
Dec 31, 2020	16.66B	-228.00M	-1.35%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.